@article{article, title  = {{Impact of oral abrocitinib on signs, symptoms and quality of life among adolescents with moderate‐to‐severe atopic dermatitis : an analysis of patient‐reported outcomes}},

 publisher = {{Wiley}},

 url = {{}},

 year = {{2021}},

 month = {{12}},

 author = {{Cork MJ and McMichael A and Teng J and Valdez H and Rojo R and Chan G and Zhang F and Myers DE and DiBonaventura M}},

 doi = {{10.1111/jdv.17792}},

 volume = {{36}},

 journal = {{Journal of the European Academy of Dermatology and Venereology}},

 issue = {{3}},

 pages = {{422-433}},

 note = {{Accessed on 2025/11/05}}}